Cost Recovery Initiative

Cost recovery is a federal government policy which requires government departments to consider charging fees for services. Fees for certain drug and medical device regulatory activities were implemented between 1995 and 2000, and reviewed between 2000 and 2002.

The Cost Recovery Initiative 2 (CRI-2) project is using the results of the fee review to implement changes to the drug and medical device fee regulations.

Documents relating to the review of these fees and the implementation of changes, including consultation activities and the development of costing, fee and revenue allocation (i.e. financial) models, will be posted to the website.

	HPFB Drug Cost Recovery Initiative 2 Action Plan Date: 2001-10-01
	Final Report Review of the Therapeutic Products Programme Cost Recovery Initiative - Executive Summary Date: 2000-06-23
	Financial Models Reference Committee

		Terms of Reference 2002-11-08
		Membership 2002-10-30
		Financial Models Project - Final Report 2004-09-10
		Meetings
		2004-06-30 Reference Committee on Financial Models Project - Summary Report 2004-04-26 Agenda Business Transformation Initiative - Update Financial Models Project - Overview Financial Models Project - Status 2003-09-08 Agenda Financial Models Reference Committee - Improvement Agenda Financial Models Project - Update Business Transformation Update Financial Models Project - Early Results (Progestic) 2003-03-04 Agenda Financial Models Project - Update Financial Models Project - Update Revised Business Transformation Initiative Financial Models Project - Update - Proposed Approach 2002-11-07 Agenda Financial Models Project - Introduction Draft Financial Models Project Management Plan - Presentation Draft Financial Models Project Management Plan - Discussion 2002-06-18 Financial Models Reference Committee - Call Letter